Shares of biopharmaceutical company Enlivex Therapeutics, whose securities are traded on the Nasdaq exchange, rose after the announcement of its intention to raise $212 million to create a “digital treasury” based on the RAIN token, against which the value of the token itself increased by 115% over the past day.
Enlivex plans to conduct a private placement (PIPE), in which it will issue 212 million new shares at a price of $1 per share, which is 11.5% higher than last Friday’s closing price. The company intends to use all the funds raised to purchase RAIN tokens, while Enlivex will retain its core business profile in biopharmaceuticals.
The market reacted positively to the announcement: at the end of trading on Monday, Enlivex’s share price rose by about 13%, while the RAIN token rose by 115% over the past 24 hours, the publication notes.
RAIN is the native token of the decentralized prediction market on the Arbitrum blockchain, where users can bet on the outcome of real-world events — from elections to show business events — without intermediaries, using smart contracts for settlements and transparency.
Enlivex also announced that after the deal is completed, former Italian Prime Minister Matteo Renzi will join the company’s board of directors, which management expects will strengthen the issuer’s international position and increase investor confidence.
Enlivex’s interest in prediction markets coincides with the rapid growth of this segment after the 2024 elections: the Polymarket platform has attracted about $2 billion in investments from ICE, the parent company of the New York Stock Exchange, and Kalshi has attracted about $1 billion from Sequoia Capital and other investors, No Worries emphasizes, citing a statement by Enlivex CEO Chai Novik that institutional interest in leading prediction market players indicates the maturity of the industry and its potential.